8 terminated. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Angina Pectoris: new trials by email Literature Review of Angina Pectoris trials Research Report on Angina Pectoris
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction CLBS16, Placebo - Coronary Microvascular Dysfunction, Coronary Microvascular Disease | Phase 2 | Terminated | Lisata Therapeutics, Inc. | 34 | 2020-10-29 | 2026-05-04 |
| Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents Ranolazine, Sugar pill - Angina | Phase 2 | Terminated | North Florida Foundation for Research and Education | 5 | 2015-08-01 | 2019-06-11 |
| Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy Eleclazine, Placebo - Hypertrophic Cardiomyopathy | Phase 2 / Phase 3 | Terminated | Gilead Sciences | 172 | 2015-02-05 | 2018-09-24 |
| Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina Febuxostat, Placebo - Angina | Phase 2 | Terminated | Takeda | 1 | 2012-07-01 | 2013-12-20 |
| Evaluation of Exercise Treadmill Test (ETT) Indices in Participants With Cardiovascular Disease Ranolazine 500 mg - Atherosclerotic Coronary Vascular Disease | Phase 2 | Terminated | Novartis Pharmaceuticals | 14 | 2012-03-09 | 2021-06-18 |
| Serp-1 for the Treatment of Acute Coronary Syndrome Serine proteinase-1 (Serp-1) - Unstable Angina, Coronary Atherosclerosis | Phase 2 | Terminated | Viron Therapeutics Inc | 72 | 2005-10-01 | 2009-02-06 |
| Stem Cell Study for Patients With Heart Disease Autologous peripheral blood CD34 positive cell therapy - Chest Pain, Chronic Myocardial Ischemia | Phase 1 / Phase 2 | Terminated | Foundation for Biomedical Research and Innovation | 1 | 2005-09-01 | 2011-06-22 |
| Feasibility Study of Photopheresis Post Angioplasty Photopheresis Post Angioplasty - Stable Angina Pectoris, Unstable Angina Pectoris | Phase 2 | Terminated | Atlantic Health System | 120 | 2000-08-01 | 2014-01-16 |
Angina, Unstable (2) · Coronary Artery Disease (2) · Acute Coronary Syndrome (1) · Angina, Stable (1) · Cardiomyopathies (1) · Cardiomyopathy, Hypertrophic (1) · Cardiomyopathy, Hypertrophic, Familial (1) · Cardiovascular Diseases (1) · Chest Pain (1) · Coronary Restenosis (1) · Dyspnea (1) · Heart Diseases (1) · Heart Failure (1) · Hypertrophy (1)
Neurologic Manifestations (8) · Pathological Conditions, Signs and Symptoms (8) · Signs and Symptoms (8) · Cardiovascular Diseases (7) · Chest Pain (7) · Heart Diseases (7) · Myocardial Ischemia (7) · Pain (7) · Vascular Diseases (7) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Coronary Disease (2) · Aortic Stenosis, Subvalvular (1) · Aortic Valve Disease (1)
Ranolazine (2) · Febuxostat (1) · Sugars (1) · eleclazine (1)
Atlantic Health System (1) · Foundation for Biomedical Research and Innovation (1) · Gilead Sciences (1) · Lisata Therapeutics, Inc. (1) · North Florida Foundation for Research and Education (1) · Novartis Pharmaceuticals (1) · Takeda (1) · Viron Therapeutics Inc (1)
United States (7) · Australia (1) · Canada (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1) · United Kingdom (1)
Alexandra Lucas, MD (1) · Anthony A Bavry, MD, MPH (1) · Emil Bisaccia, MD (1) · Jean-Claude Tardif, MD (1) · Kristen K Buck, MD (1) · Takayuki Asahara, M.D. (1)